The benefit of simplification from tipranavir/ritonavir 500/200 bid to 500/100 bid guided by therapeutic drug monitoring

1. Rodríguez-Novoa, S.
2. Morello, J.
3. Blanco, F.
4. Vispo, E.
5. Barreiro, P.
6. Gonzalez-Pardo, G.
7. Jiménez-Nácher, I.
8. González-Lahoz, J.
9. Soriano, V.